CENTER ID: | TrcrB.19501.b |
ORGANISM: | Trypanosoma cruzi CL Brener |
ASSOCIATED DISEASE: | |
CURRENT STATUS: | purified |
COMMUNITY REQUEST: | True |
NIH RISK GROUP: | 2 |
SELECT AGENT: | False |
NIH PRIORITY pathogens category: |
unclassified |
CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
---|---|---|---|---|---|
TrcrB.19501.b.B2.GE40730 | C-term domain | 334 | 620 | ||
TrcrB.19501.b.B4.GE41052 | N-extended J-binding domain | 84 | 279 |
CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
---|---|---|---|---|---|
TrcrB.19501.b.B4.PS38208 | N-extended J-binding domain | 84 | 279 |
METHOD | RESULTS |
---|---|
comparative modelling | Robetta_79391 |
RESOURCE | REFERENCE ID |
---|---|
EuPathDB: | TriTrypDB:TcCLB.510967.16 |
UniProt: | Q4CUX1 |
HARVESTED ON: | 11/8/2016 |
SEQUENCED ON: | 11/8/2016 |
EXPECTED MW: | 33kDa |
OBSERVED MW: | 31kDa |
ANTIBIOTIC MARKER: | ampicillin |
COUNT OF EXPRESSION COLONIES: | Good (10-50) |
TOTAL EXPRESSION LEVEL: | Moderate Expression |
SOLUBLE EXPRESSION LEVEL | No Expression |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
SEQUENCING RESULT: | |
PERCENT IDENTITY: | 98 |
PERCENT COVERAGE: | 100 |
HARVESTED ON: | 1/4/2017 |
SEQUENCED ON: | 1/5/2017 |
EXPECTED MW: | 24kDa |
OBSERVED MW: | 24kDa |
ANTIBIOTIC MARKER: | ampicillin |
COUNT OF EXPRESSION COLONIES: | Many (50-100) |
TOTAL EXPRESSION LEVEL: | Moderate Expression |
SOLUBLE EXPRESSION LEVEL | Moderate Expression |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
SEQUENCING RESULT: | |
PERCENT IDENTITY: | 100 |
PERCENT COVERAGE: | 100 |
PURIFICATION DATe: | 2/22/2017 |
CONCENTRATION: | 21.53mg/ml |
OBSERVED MW: | 24kDa |
EXPRESSION LEVEL: | Moderate Expression |
PROTEIN PURIFICATION BUFFER: | SEC: 20 mM HEPES pH 7.0, 300 mM NaCl, 5% glycerol, 1 mM TCEP |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
VIAL COUNT (approx.): | 31 |
VIAL VOLUME: | 200µl |
PERCENT IDENTITY: | 100 |
PERCENT COVERAGE: | 100 |